亿德体育
About Henlius
Company Profile
亿德体育:Corporate Culture
Honor
亿德体育:Board of Directors
Management Team
Advisory Committee
Product
亿德体育:Marketed Products
亿德体育:Products in R&D
亿德体育:Clinical Trial
亿德体育:Science & Technology
亿德体育:R&D Result
亿德体育:Innovation Centre
Technology Platform
Quality Management
Manufacturing
Collaborations
Investor Relations
亿德体育:Information Disclosure
亿德体育:Corporate Governance
Financial Reports
Stock Info
IR Calendar
Investor Presentation
亿德体育:Analyst Coverage
亿德体育:Contact Information
Media
Press Release
Multi-media
Media Reports
Media Enquiry
Careers
亿德体育:Talent Philosophy
Staff Life
亿德体育:Training and Development
亿德体育:Contact Us
亿德体育:Contact Information
亿德体育:Customer Message
Privacy
亿德体育:Legal Statement
亿德体育:Compliance
EN
简体
EN
繁體
Home
亿德体育:About Henlius
亿德体育:Company Profile
亿德体育:Corporate Culture
Honor
Board of Directors
Management Team
Advisory Committee
Product
亿德体育:Marketed Products
亿德体育:Products in R&D
亿德体育:Clinical Trial
Science & Technology
R&D Result
Innovation Centre
Technology Platform
亿德体育:Quality Management
Manufacturing
亿德体育:Collaborations
亿德体育:Investor Relations
亿德体育:Information Disclosure
Listing Documents
亿德体育:Announcement & Circulars
Corporate Governance
亿德体育:Financial Reports
亿德体育:Stock Info
亿德体育:IR Calendar
Investor Presentation
亿德体育:Analyst Coverage
亿德体育:Contact Information
Media
Press Release
2022
2021
2020
2019
2018
2017
2016
2015
2014
亿德体育:Multi-media
Company
Event
亿德体育:Popular Science
Media Reports
亿德体育:Media Enquiry
Careers
亿德体育:Talent Philosophy
亿德体育:Staff Life
Training and Development
Job Opportunities
Contact Us
Contact Information
亿德体育:Customer Message
Privacy
Legal Statement
亿德体育:Compliance
Be the most trusted biotech company
Press Release
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
亿德体育:Multi-media
Company
Popular Science
亿德体育:Highlights
Download
Media Reports
亿德体育:Media Enquiry
2021-11-18
Making biologic medicines more accessible
Global biopharmaceutical company Henlius aims to greatly improve patient well-being with affordable and innovative biologic medicines
2020-02-14
Shanghai Henlius CEO Wants To Capitalize On First-Mover Status
Generics Bulletin
2019-05-09
An original force in biosimilars
Nature Research
2018-06-27
Growing Antibody Industry in China Sees Major Opportunities
GEN Exclusives
2018-05-10
China's global investment push opens doors for domestic biotechs
BIOPHARMA DIVE
var _hmt = _hmt || []; (function() { var hm = document.createElement("script"); hm.src = "https://hm.baidu.com/hm.js?90c4d9819bca8c9bf01e7898dd269864"; var s = document.getElementsByTagName("script")[0]; s.parentNode.insertBefore(hm, s); })(); !function(p){"use strict";!function(t){var s=window,e=document,i=p,c="".concat("https:"===e.location.protocol?"https://":"http://","sdk.51.la/js-sdk-pro.min.js"),n=e.createElement("script"),r=e.getElementsByTagName("script")[0];n.type="text/javascript",n.setAttribute("charset","UTF-8"),n.async=!0,n.src=c,n.id="LA_COLLECT",i.d=n;var o=function(){s.LA.ids.push(i)};s.LA?s.LA.ids&&o():(s.LA=p,s.LA.ids=[],o()),r.parentNode.insertBefore(n,r)}()}({id:"K9y7iMpaU8NS42Fm",ck:"K9y7iMpaU8NS42Fm"});
亿德体育|亿德体育官网 - 登录入口
米乐m6 | m6米乐
米乐m6 - 官网登录
米乐m6 - 米乐m6官网
米乐m6 - 米乐m6官网 - APP下载